Status:
RECRUITING
Implementation of Support in the Care of Adults Living With Type 1 Diabetes
Lead Sponsor:
McGill University
Collaborating Sponsors:
Institut de Recherches Cliniques de Montreal
Centre Hospitalier de l'Universite Laval (CHUL)
Conditions:
Type 1 Diabetes
Metabolic Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will co...
Detailed Description
Type 1 diabetes (T1D) is a chronic condition which requires life-sustaining insulin therapy as well as knowledge, skills and confidence to self-manage. Tailored diabetes self-management education (DSM...
Eligibility Criteria
Inclusion
- Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)
- Have access to Internet
- Use of an active email address
- Comprehension of English or French
- Live in Canada
Exclusion
- \- Unable to use the Support platform
Key Trial Info
Start Date :
May 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT06069583
Start Date
May 5 2024
End Date
October 1 2027
Last Update
September 25 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada, H2W 1R7
2
Centre hospitalier de l'université de Montreal
Montreal, Quebec, Canada, H2X 0C1
3
Centre hospitalier de Quebec, Université Laval
Québec, Quebec, Canada, G1V 0E8
4
Centre de médecine métabolique de Lanaudière
Terrebonne, Quebec, Canada, J6x 4P7